Alligator Bioscience AB

Lund, Sweden, November 11, 2008 - Alligator Bioscience, the protein optimization company, is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference on Wednesday, November 12, at 12:25 pm US Eastern Time /18:25 Central European Time, at the New York Palace Hotel in New York City, US. The presentation, given by Alligator's chief executive officer, Dr Gun-Britt Fransson, will provide an update on the company's protein optimization technology, FIND® and how it is exploited to build a competitive pipeline of discovery phase biopharmaceuticals. Selected discovery programs will also be disclosed: ADC-1001 a second generation IL-1 receptor antagonist and ADC-1004 a selective high potent C5aR antagonist.